The historic rise of Viagra has firmly established as a symbol of pharmaceutical success, however its legacy within the broader sector now triggers questions about long-term gains. Alternative versions are diminishing patent protection , leading to concerns that betting on companies heavily reliant to Viagra's former influence could be a speculativ